Investigators for the Government Accountability Office have found that companies that offer drug coverage to Medicare beneficiaries often provide inaccurate or incomplete data. This is important because the premise of Part D is that out of dozens of plans, patients will choose the one that best fits their needs. But this isn't possible if they're receiving inaccurate data. The GAO also found that customer service reps often misquoted how much the plan would cost annually and that consumers either end up paying more or receiving inadequate coverage.
The Bush administration responded by saying that the questions investigators posed to customer service representatives were misleading. Spokespeople did agree, however, that "beneficiaries should be able to count on the customer service" when choosing their coverage.
- see this The New York Times article